Plenary and Panel Speakers
Henning BOHN, is Professor of Economics at the University of California, Santa Barbara. He has served as consultant to the World Bank, the Federal Reserve, and other major government institutions. His scholarly research covers macroeconomics, public economic, and international economics, including publications on government debt, public pensions, the sustainability of budget deficits, intergenerational risk sharing, optimal taxation, and demographic change.
Professor Bohn studied economics and mathematics at the University of Mannheim, Germany, and he earned a PhD in Business from Stanford University under the guidance of Ben Bernanke. He was on the finance faculty at the Wharton School (University of Pennsylvania) before moving to Santa Barbara in 1992. He has served as Chair of the UCSB Academic Senate and as Trustee of the UCSB Foundation.
Guy COUGHLAN, USS. Guy Coughlan is the Chief Financial Risk Officer at Universities Superannuation Scheme, a UK defined benefit pension plan with assets of £49 billion. Guy joined USS in 2015 as a member of the executive team to head up the newly-created group risk function, with responsibility for solvency, funding and investment risks, as well as operational and cyber risks.
Guy spent much of his career at J.P. Morgan where he was a Managing Director and over 17 years held various roles including Global Head of Longevity Solutions, Global Head of ALM Advisory, and Co-head of European Pension Advisory. During his time at J.P. Morgan Guy advised pension plans, corporations and insurance companies on investment, risk management and ALM. He began in fixed income research and was a member of the pioneering Risk Metrics team, in which he led the design, development and marketing of the first general-purpose commercial value-at-risk system called FourFifteen. In 1999 he founded the Global ALMAdvisory group and set up J.P. Morgan's longevity business in 2007. In this role, Guy led the development of Life Metrics, an open-source platform for longevity risk management that included longevity models and indices. In 2008 he was involved in executing the world's first longevity hedges using capital markets swaps.
In 2011 Guy joined Pacific Global Advisors, a business providing fiduciary management and advisory services to US pension plans. He served as a member of the management team with responsibility for the Risk function, the Actuarial team, and the ALM function.
Guy played a central role in establishing the Life & Longevity Markets Association (LLMA), a cross-industry body set up to promote the market for longevity risk transfer, serving as the inaugural chairman of the LLMA's Technical Committee. In 2012 he served on the US Societyof Actuaries' Longevity Task Force.Guy has aDPhil (i.e., PhD) in physics from Oxford University, and also holds a BSc degree from the University of Western Australia and an MBA from Henley Business School in the UK.
André DE VRIES, Vice President, Business Development, EMEA, Global Financial Solutions at RGA focuses on capital motivated reinsurance, including longevity. André was directly involved in the longevity transactions that RGA implemented for Delta Lloyd in the Netherlands in 2014 and 2015. He is based in Amsterdam and has worked in the financial industry for more than 15 years.
He began his career at ABN AMRO Bank as a quantitative consultant analyzing pre-payment risk in mortgage portfolios and deriving replicating portfolios for savings products. Subsequently, he joined the Credit Risk Modelling group heading the team responsible for measuring counter party credit exposure on derivative portfolios. Thereafter, he moved to the investment bank as a member of the Insurance Solutions Group where André structured life insurance reserve financing transactions in the US and Canada.
Andréstudied Econometrics at the University of Tilburg and Actuarial Science at the University of Amsterdam.
Michel DENUIT, Louvain (Actuarial Science). Michel Denuit received a Master's degree in Mathematics, a Master's degree in Actuarial Science and a PhD degree in Statistics, all from ULB (Brussels, Belgium).
He devoted all his career to teaching and research in actuarial science, at UCL (Louvain-la-Neuve, Belgium) where he is professor in the Institute of Statistics, Biostatistics and Actuarial Science. He serves as Chairman of the UCL Master in Actuarial Science.
He has held several visiting appointments at universities and research institutes, including the Centre for Risk and Insurance Studies of the KU Leuven (Leuven, Belgium), the Department of Actuarial Science of the University of Lausanne (Switzerland), the Institute for Finance and Insurance of the Lyon 1 University (ISFA, Lyon, France), and the National Institute of Statistics and Applied Economics of Rabat (INSEA, Rabat, Marocco).
He has done extensive research in the areas of mathematical risk theory and actuarial pricing. He specialized in applying advanced probabilistic and statistical methods to solve actuarial problems. In addition to his books devoted to P&C and health insurance, he co-authored “Modelling Longevity Dynamics for Pensions and Annuity Business “ with E. Pitacco, S. Haberman, and A. Olivieri (Oxford University Press, 2009) as well as “Construction de Tables de Mortalité Périodiques et Prospectives” with A. Delwarde (Collection Audit-Actuariat-Assurance, Economica, Paris, 2005).
He conducted several projects with major European (re)insurance companies and banks. He has served as Director of the UCL Institute of Statistics, as well as on several professional actuarial committees in Belgium and in the EU.
For a detailed CV and a list of publications, see http://www.uclouvain.be/michel.denuit
Mark FLINT is Head of Impaired Annuities at SCOR Global Life UK Branch, where he is leading SCOR’s entry into the UK enhanced annuity market. He was previously Director of Longevity at Munich Re UK Life Branch.
Mark did a Mechanical Engineering Degree at Southampton University. He then switched careers and qualified as a Fellow of the Institute of Actuaries in 1996. After several years as an adviser to pension scheme trustees and sponsoring employers Mark went abroad, working in Chicago and Hong Kong.
Mark has worked in the UK Life Reinsurance market for fifteen years, specialising in longevity business since 2007.
Serge GUERIN, ESG Paris, is a Sociologist and Professor at the Paris School of Business. Serge Guérinteaches in the MSc. program in Silver Economy at IEP Paris. Research associate at the Edgar Morin Centre ( EHESS / CNRS ), he also leads the Social Innovation Fund of the Federation of Social Housing Enteprises.
Expert on ageing and intergenerational issues, he defends the need for a policy of care and social assistance. In this context, Serge Guerin has contributed to the emergence of the volunteer caregivers category in the public space.
He has authored twenty books, and has just published Silver Génération, 10 idées faussessur les seniors (Silver generation, 10 misconceptions about seniors), Michalon, 2015.
Denis JACQUAT is Member of French Parliament (Député)of the Moselle since 1986. He is a member of the Social Affairs Commission in the National Assembly in France.
Recognized expert in the social field, he was, for many years reviewer of the Old-Age Insurance budget within the PLFSS (project of law of social security financing in France) and is PLFSS reviewer for the 2015 workers' compensation - occupational diseases.He serves on the Social Affairs Committee, Health and Sustainable Development Council of Europe. He is also member of the Board of the Pensions (COR)and has chaired the Supervisory Board of CNAV.
Otolarngologist, Denis Jacquat is also very interested in the health, sport and disability area.
Amy KESSLER is senior vice president and head of Longevity Risk Transfer within Prudential's Pension Risk Transfer business. In this role, Amy leads Prudential’s longevity reinsurance business globally and serves on the senior leadership team for Prudential’s pension risk transfer efforts in the United States. In 2011, Amy led Prudential's successful launch of its longevity reinsurance product and, together with her exceptional team, has closed more than $37 billion in international reinsurance transactions since,covering members of nearly 200 pension funds in the United Kingdom, including British Airways and Rolls Royce. In 2014, Amy led Prudential’s reinsurance team in the largest and most innovative longevity risk transfer transaction on record for the BT Pension Scheme – this transaction was recognized as Deal of the Year by Risk Magazine and earned Prudential top honors as Reinsurer of the Year. With more than 25 years of experience, Amy is an innovator whose work helps pension funds proactively manage longevity risk and create retirement security for their members.
Tom KIRKWOOD is Professor and Distinguished Research Fellow at Newcastle University, where he directed the Institute for Ageing and Health from 2004-2011. His research is on the science of ageing and on how genetic and non-genetic factors, such as nutrition, influence longevity and health in old age. He is an elected Fellow of the UK Academy of Medical Sciences and of the Royal College of Physicians of Edinburgh and an Honorary Fellow of the Faculty and Institute of Actuaries. He advises a range of national and international organizations on the opportunities and challenges of population ageing. He has published many research papers, won several international prizes for his research, and is a frequent contributor to television, radio and newspapers. His books include the award-winning ‘Time of Our Lives: The Science of Human Ageing’, ‘Chance, Development and Ageing’, ‘The End of Age’ based on his BBC Reith Lectures in 2001, and ‘An Age of Wonders: the Story of the Newcastle 85+ Study’
Ronald LEE is a demographer and economist, with an MA in Demography from Berkeley and a Ph.D. in Economics from Harvard. Since 1979 he has been at the University of California at Berkeley, currently as a Professor of the Graduate School, and Founding Director (Emeritus) of the Center for the Economics and Demography of Aging. Heis also a Research Associate of the NBER. Throughout his career, he has taught economic demography. With Carter he developed the Lee-Carter method for modeling and forecasting mortality which is now widely used in government and finance. He currently co-chairs a committee of the National Academy of Sciences that is analyzing the increasing inequality in life expectancy by economic status in the United States and the implications of this trend for the progressivity of the major public programs for the elderly, including pensions,health care and long term care.
His current research focuses on the macroeconomic consequences of changing population age distributions and on intergenerational transfers and population aging. He co-directs with Andrew Mason the National Transfer Accounts project (NTA), which currently includes collaborating research teams in 47 countries. The project estimates intergenerational flows of resources by age through the public and private sectors (NTAccounts.org), with applications to the consequences of population aging, the demographic dividends realized during the demographic transition, fiscal stability of public and private transfer programs, the interrelation of public and private transfer programs and many other topics. NTA is now expanding to include gender and home production. He also continues to work on modeling and forecasting demographic variables including mortality (he is co-author of the Lee-Carter model) and on evolutionary biodemography. For five years he has co-chaired the National Academy of Sciences Committee on the Long-run Macroeconomic Effects of the Aging U.S. Population.
He is an elected member of the US National Academy of Sciences, American Association for the Advancement of Science, American Academy of Arts and Sciences, the American Philosophical Society, and a Corresponding Fellow of the British Academy. He is past President of the Population Association of America, and recipient of the Mindel C. Sheps Award for research in Mathematical Demography, the Irene B. Taeuber Award for outstanding contributions in the field of demography, and an Honorary Doctorate, honoris causa,from Lund University, Sweden. He has served on both the National Advisory Committee on Aging (NIA Council) and the National Advisory Committee on Child Health and Human Development (NICHD Council).
Jean-HervéLORENZI, Major at the Agrégation des facultés de droit etsciences economies (Faculties of Law and Economics) in 1975, is Chairman of the Cercle des économistes (the famous circle of French economists), holder of the Chair“Demographic Transition, Economic Transition within the Fondation du Risque (Foundationof the Risk) and Chairman of the Pôle de Compétitivité (Pole of Competitiveness)“Finance Innovation”. He is a member of the Board of Directors of the Edmond deRothschild France Group, of the supervisory board of Euler Hermes and the Boards of directors (board meetings) of the Médéric Alzheimer Foundation, the IDATE and the BNP Paribas Cardif. He was Professor at the university Paris-Dauphineand the member of council of economic analysis. He has notably published: Un monde de violences. L'économie mondiale2015-2030, Paris, Eyrolles, 2014 ; Rajeunissementet vieillissement de la France (with J. Pelletan and A. Villemeur), Paris, Descartes & Cie, 2012 ; Droitecontre gauche, (with O. Pastré), Paris, Fayard, 2012 ; Le fabuleux destin d'une puissanceintermédiaire, Paris, Grasset, 2011 ; Le choc des populations : guerre ou paix, (in collaboration with P.Dockès), Paris, Fayard, 2010.
Jessica MOSHER is a policy analyst in the Private Pension Unit of the OECD and co-author of the OECD publication on MortalityAssumptions and Longevity Risk along with Mr. Pablo Antolin. In addition to her work on longevity risk, she is involved in topics relating to annuity products and the regulation of insurer and pension fund investment. She has previous experience working in risk management for an international insurance company where she was mainly responsible for developing the global modelling of mortality and longevity risks under Solvency II. She was also involved in the Life and Longevity Markets Association (LLMA) and its work on basis risk for index-based longevity swaps. Ms. Mosher is a Fellow of the Society of Actuaries, holds a Bachelors degree in Economics from the Wharton School of the University of Pennsylvania and is a candidate for a Masters degree in Behavioural Science from the London School of Economics and Political Science.
Avery MICHAELSON is a Vice President in the Insurance & Pension Solutions team at Société Générale. In this role he is working to develop a large and liquid market for trading longevity risk globally, and has created innovative reinsurance and capital market solutions that provide clients with a powerful risk and capital management tool. Over his career, Mr. Michaelson has held various roles in the insurance-linked securities and reinsurance markets – consistently focusing on longevity and mortality risks. Previously he worked at Coventry Capital, a leader in the Life Settlement industry; and began his career at Deutsche Bank in the Longevity Derivatives Group. He graduated Magna Cum Laude with a BS in Finance from The Wharton School at the University of Pennsylvania.
Ragnar NORBERG, born in 1945, is a Norwegian statistician and actuary. His academic career started at the University of Oslo, where he obtained his two MSc degrees (cand.act and cand.real) and his doctorate (Dr.philos)and was recruited as an Assistant Professor in 1972. He was Professor of Statistics with Insurance Mathematics at the University of Oslo (1984-1990), Professor of Insurance Mathematics at the University of Copenhagen (1991-2000), and Professor of Statistics at the London School of Economics from 2000 (Emeritus since 2010).After retirement he was a full time Research Officer (Chercheur) at the University of Lyon 1 for four years (2011-2014). In between he has been employed full time as Research Officer at Storebrand Insurance (1980-1981), Guest Professor at ETH Zuerich (1981-1982) and the University of Melbourne (1998), hehas taught courses at the University of Strasbourg and the Free University of Brussels, and he has paid longer visits to a number of academic institutions including Moscow State University, Stanford University, and the University of the Aegean.He is elected member of the International Statistical Institute, Honorary member of the Institute of Actuaries, Honorary member (Socio Corrispondente) of the Istituto Italiano degli Attuari, and Honorary Doctor of Science at Heriot-WattUniversity, Edinburgh. His research addresses a broad range of topics in risk theory, insurance mathematics (life, non-life, and credibility theory), financial mathematics, and related areas in statistics and probability. He is well knownin the international scientific and professional communities as a writer, an organizer of conferences, an editor of academic journals, and a speaker in a long list of major conferences, academic departments, and learned societies around the world. Personal homepage is at http://isfa.univ-lyon1.fr/~norberg with links to full cv and selected publications.
Professeur (Full time Professor) at Université Lyon 1 since September 2003,
Laboratoire de Sciences Actuarielle et Financière (équipe d’accueil 2429)
1991–2012 Actuaire associé (Partneractuary) at WINTER & Associés
Since 2013 Partner Actuary at PRIM’ACT
– HDR in actuarial sciences
– PhD Thesis, in actuarial sciences
Research interests: Solvency II (Pillars 1 and 2), IFRS,MCEV : internal models, ORSA quantitative models, market consistent valuations,economic scenario generators (both risk-neutral and historical views) -Modeling censored and truncated data (mortality, disability, lapse, etc.) :best estimate assumptions for reserve calculations, longevity risk evaluation,catastrophic risk in life insurance - Stochastic models and simulation techniques : best estimate and SCR calculation, both in standard model and internal model ; time optimization for Monte-Carlo methods. – Liabilities valorization and asset-liability management in life insurance.
E-mail: firstname.lastname@example.org Web: http://www.ressources-actuarielles.net
Jean-Michel RICARD, Association Siel Bleu. In 1997 Jean-Michel Ricard and Jean-Daniel MULLER completed their Masters in Sports Management at the college of Science and Technology in Physical and Sports Activities at the University of Strasbourg. However, Jean-Daniel and Jean-Michel didn’t wish to go into traditional teaching; rather, they decided to begin offering courses in Adapted Physical Activity for older people, with the aim both to provide preventative healthcare and to safeguard autonomy and independence.
As the organisation has developed, the beneficiaries of its work have expanded. Today, the organisation’s activities aim to provide life-long preventative healthcare and improved quality of life for children, pregnant women, senior citizens and the elderly as well as people with disabilities. The second objective of the organisation is to use APA as a complimentary therapy for people suffering from chronic illness such as cancer, diabetes, obesity, multiple sclerosis, Parkinson’s disease and more.
Today the 400 specialised graduates employed by the Groupe Associatif Siel Bleu provide services each week for more than 80,000 beneficiaries in France alone.
For more than 17 years the order of the day has been financial accessibility for all. This is why the Siel Bleu Foundation came to be.
Jean-Marie ROBINE is a Research Director at INSERM, the FrenchNational Institute of Health and Medical Research (http://www.inserm.fr), within the CERMES Research group in Paris and the Unit 1198 in Montpellier where he heads the research team Biodemography of longevity and vitality.He is also a Study Director at the advanced school Ecole pratique des hautes études (http://www.ephe.sorbonne.fr) in Paris. He studies human longevity, with the aim of understanding the relations between health and longevity. In particular, he measures the impact that the increase in adult life durations may have on the health status of the elderly population.
Since its creation in 1989, he has been the coordinator of the International Network on Health Expectancy (REVES), which brings together more some 100researchers worldwide (www.reves-network.org). He was the project leader of the European Joint Action EHLEIS(2011-2014) which provided analysis ofdisability-free life expectancies in the European Union. He is co-responsible for the development of the International Database on Longevity (IDL) in association with the Max Planck Institute for Demographic Research (Rostock) and INED (Paris). He is the project leader of the healthy longevity project granted by AXA Research Fund: the Five-Country Oldest Old Project (5-COOP).He is one of the Directors of the new French Research Consortium on ageing and longevity (GDR CNRS 3662, 2014-2017).
Laurent SCHWARTZ, Ecole Polytechnique Paris (Oncology), is a Harvard trained medical oncologist. He is working at the Assistance Publique des Hôpitaux de Paris and at the Ecole Polytechnique. He is author of more than 200 peer reviewed publications and of several books. Despite huge investments and cost to the community, standardised cancer death rates (the number of death per 100 000 persons at a given age) has not changed drastically, in the western world, in the past sixty years. For example despite the invention and diffusion of radical prostatectomy,radiation therapy, PSA screening and availability of new drugs, aggregate data of death certificates demonstrate only a drop of 0,5% in prostate cancer death rate since 1960.Cancer is probably a simple straightforward metabolic disease. Cancer cells ingest large quantities of glucose than they cannot fully digest resulting in cell division, increased pressure and metastatic spread.Accordingly, non expensive, already available drugs targeting the tumour metabolism slow tumour growth in every murine tumour model. Metabolic treatment of patients suffering from incurable metastatic disease delays tumour progression and death. Treatment can be further improved using re-purposing of other well known drugs such as metformin (antibiabetic), digoxin (heart disease) or diclofenac (anti-inflammatory). It is probable that cancer death rates will be improved. Clinical trials must be deregulated in order to facilitate the use of old molecules with a well established safety profile. It is probable that the radical simplification of cancer biology will have a profound impact on society.
Philip SIMPSON is a principal and consulting actuary in the London office of Milliman. Philip specializes in life insurance and reinsurance. His consulting assignments include longevity swaps,reinsurance, annuities, mergers and acquisitions, financial reporting, company reconstructions, new company launches, and product design and pricing. Philip had advised a wide variety of financial institutions on longevity related projects including product pricing and design, reinsurance, securitisations and transactions. Philip has advised buyers and purchasers on a large number of mergers and acquisitions, including ones with significant longevity exposures. Prior to being a consultant, Philip worked in reinsurance,where his experience included design and review of reinsurance programs and a wide range of annuity, life and health insurance products. Philip is a member of the UK actuarial profession’s Research Thought Leadership Committee and its Mortality Research Steering Committee. Philip has a BSc, Mathematics and Theoretical Physics from St Andrews University and an MBA specializing in Financial Risk Management from Edinburgh Business School.
Pierre-Henri TAVOILLOT is Maître de conférences in philosophy at Université Paris Sorbonne-Paris IV.He is president of the Collège de philosophie and co-director of the collection « Le Nouveau collège dephilosophie » published by Grasset.Previously, Pierre-Henri served as advisor at the cabinet of the Ministry of Education (2000-2002) and member of the Society Analysis Committee (referreing to the Prime Minister) from 2004 to 2013. He has written several books, andreceived the 2007 François Furet Award for his book Philosophie des âges dela vie, co-authored with Eric Deschavanne (Paris, Grasset, 2007; reed.Hachette Pluriel, 2008).
AlexZHAVORONKOV, PhD is the CEO of Insilico Medicine, Inc a Baltimore-based company utilizing big data analysis and deep learning for aging research and drug discovery. He also heads the International Aging Research Portfolio (IARP) knowledge management system for aging research and serves as the chief science officer of the Biogerontology Research Foundation in the UK.
Prior to Insilico Medicine, he co-founded the First Oncology Research and Advisory Center (FORAC), served as the director of ATI Technologies (Nasdaq: AMD) and asthe director of GTCBio. Dr. Zhavoronkov is the author of over forty peer-reviewed scientific as well as popular papers and books including “The Ageless Generation: how biomedical advances will transform the global economy”published by Palgrave Macmillan. He holds two bachelor degrees from Queen's University, a masters in biotechnology from Johns Hopkins University and a PhD in physics and mathematics from the Moscow State University and is the international adjunct professor at the Moscow Institute of Physics and Technology.